A study for a 69 year old man who takes Entyvio - from FDA reports

429 males aged 69 (±5) who take the same drug are studied. This is a personalized study for a 69 year old male patient who has Crohn's Disease. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Jan, 20, 2019

429 males aged 69 (±5) who take Entyvio are studied.

Number of reports submitted per year:

Entyvio for a 69-year old man.

Information of the patient in this study:

  • Age: 69
  • Gender: male
  • Conditions: Crohn's Disease
  • Drugs taken:
    • Entyvio (vedolizumab)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Headache (pain in head)
  2. High blood pressure
  3. Chest x-ray abnormal
  4. Gastritis haemorrhagic (inflammation of stomach with bleeding)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Gastritis (inflammation of stomach)
  7. Pulse absent
  8. Intestinal resection
  9. Pain in extremity
  10. Weight decreased
1 - 6 months:
  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Anorectal abscess
  3. Fever
  4. Pain
  5. Escherichia infection (bacterial infection by escherichia coli)
  6. Infection
  7. Cellulitis (infection under the skin)
  8. Oesophageal varices haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)
  9. Pain in extremity
  10. Dizziness
6 - 12 months:
  1. High blood pressure
  2. Lung neoplasm malignant (cancer tumour of lung)
  3. Drug ineffective
  4. Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles)
  5. Depression
  6. Heart rate decreased
  7. Tumor perforation
  8. Hepatocellular carcinoma (liver cancer)
  9. Tumor haemorrhage
  10. Abdominal pain
1 - 2 years:
  1. Weight decreased
  2. Muscle aches (muscle pain)
  3. Anorectal abscess
  4. Weakness
  5. Bone pain
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Ankylosing spondylitis (type of arthritis affecting the spine)
  8. Postoperative wound complication
  9. Joint pain
  10. Neurological symptom (symptoms of nervous system disease)
2 - 5 years:
  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
5 - 10 years:
10+ years:
not specified:
  1. High blood pressure
  2. Weakness
  3. Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine)
  4. Fatigue (feeling of tiredness)
  5. Weight decreased
  6. Diarrhea
  7. Breathing difficulty
  8. Nausea (feeling of having an urge to vomit)
  9. Joint pain
  10. Pneumonia

Top conditions involved for these people *:

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 217 people, 50.58%
  2. High Blood Pressure : 29 people, 6.76%
  3. High Blood Cholesterol : 14 people, 3.26%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 2.80%
  5. Diarrhea : 10 people, 2.33%
  6. Diabetes : 9 people, 2.10%
  7. Herpes Zoster : 9 people, 2.10%
  8. Preventive Health Care : 8 people, 1.86%
  9. Prostatomegaly (enlargement of the prostate): 8 people, 1.86%
  10. Gastric Ulcer (stomach ulcer): 7 people, 1.63%

Top co-used drugs for these people *:

  1. Amlodipine (34 people, 7.93%)
  2. Vitamin D (33 people, 7.69%)
  3. Pantoprazole (31 people, 7.23%)
  4. Synthroid (29 people, 6.76%)
  5. Vitamin B12 (28 people, 6.53%)
  6. Asa (25 people, 5.83%)
  7. Asacol (24 people, 5.59%)
  8. Imodium (20 people, 4.66%)
  9. Pentasa (19 people, 4.43%)
  10. Calcium (17 people, 3.96%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!